These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38775539)

  • 21. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis.
    Lewis S; Glen J; Dawoud D; Dias S; Cobb J; Griffin XL; Rossiter N; Reed M; Sharpin C; Stansby G; Barry P
    Lancet Haematol; 2019 Oct; 6(10):e530-e539. PubMed ID: 31444124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials.
    Haykal T; Kheiri B; Zayed Y; Barbarawi M; Miran MS; Chahine A; Katato K; Bachuwa G
    J Orthop; 2019; 16(4):312-319. PubMed ID: 30976146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials.
    Haykal T; Kheiri B; Zayed Y; Barbarawi M; Miran MS; Chahine A; Katato K; Bachuwa G
    J Orthop; 2019; 16(4):294-302. PubMed ID: 30976143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-molecular-weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement.
    Heit JA
    Thromb Res; 2001 Jan; 101(1):V163-73. PubMed ID: 11342096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
    Singh G; Prentice HA; Winston BA; Kroger EW
    J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
    Zhu J; Jiang H; Marshall B; Li J; Tang X
    Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inpatient compliance with venous thromboembolism prophylaxis after orthopaedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin.
    Haac BE; O'Hara NN; Manson TT; Slobogean GP; Castillo RC; O'Toole RV; Stein DM
    OTA Int; 2021 Dec; 4(4):e150. PubMed ID: 34765900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD005259. PubMed ID: 35993965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.
    Iorio A; Agnelli G
    Arch Intern Med; 2000 Aug 14-28; 160(15):2327-32. PubMed ID: 10927730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.
    Anderson DR; Dunbar MJ; Bohm ER; Belzile E; Kahn SR; Zukor D; Fisher W; Gofton W; Gross P; Pelet S; Crowther M; MacDonald S; Kim P; Pleasance S; Davis N; Andreou P; Wells P; Kovacs M; Rodger MA; Ramsay T; Carrier M; Vendittoli PA
    Ann Intern Med; 2013 Jun; 158(11):800-6. PubMed ID: 23732713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study.
    Sidhu V; Badge H; Churches T; Maree Naylor J; Adie S; A Harris I
    BMC Musculoskelet Disord; 2023 Aug; 24(1):629. PubMed ID: 37537580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
    Kerr DL; Butler S; Read AC; Harris IA
    ANZ J Surg; 2019 Oct; 89(10):1211-1216. PubMed ID: 31234237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.
    Heit JA; Elliott CG; Trowbridge AA; Morrey BF; Gent M; Hirsh J
    Ann Intern Med; 2000 Jun; 132(11):853-61. PubMed ID: 10836911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.